e-Robertet
/
fr
en
/
CN

Regulated financial informations

Regulated financial informations
Financial Calendar Press releases Investor presentations Financial reports Shareholders meeting
Register Contact
Register
Home Financial Informations Regulated financial informations

Financial calendar

2024 Full Year Sales press release

February 13, 2025

Investor Roadshow, London – JP Morgan

March 11, 2025

Investor Roadshow, London – BNPP-Exane

March 12, 2025

Investor Roadshow, Grasse – Jefferies

March 25, 2025

2024 Full Year Report press release

April 14, 2025

Investor Conference - Paris

April 14, 2025

2024 Full Year Report

April 17, 2025

Capital Markets Day- Grasse

May 22, 2025

2025 Annual General Meeting of Shareholders

June 4, 2025

2025 Half Year Sales press release

July 25, 2025

2025 Half Year Report press release

September 11, 2025

2025 Half-Year Report

September 18, 2025

Press releases

PRESS RELEASE ON THE CAPITAL ALLOCATION

04/02/2020 18:00

53Ko

Documents

Investors presentations

No results found!

Financial reports

FIRST SEMESTER 2020 - CONDENSED CONSOLIDATED INTERIM STATEMENTS

28/10/2020 18:00

2.48Mo

ROBERTET GROUP - FINANCIAL PERFORMANCE REPORT 2019

05/05/2020 09:00

6.66Mo

Shareholders Meeting

No results found!

Board of directors

  • Chairman :
  • Philippe MAUBERT
  • Members :
  • Christophe MAUBERT
  • Catherine CANOVAS
  • Colette ROBERT
  • Isabelle de CREMOUX
  • Lucie MAUREL-AUBERT
  • Société Maubert SA, represented by M. Elie VANNIER

STOCK MARKET INFORMATION

  • ISIN :
  • FR0000039091
  • Business Sector :
  • Chimie Pharmacie Cosmétique
  • Sector Classification :
  • 1357, Chimie de spécialité
  • Type :
  • Action – Action ordinaire Continu
  • Market :
  • NYSE Euronext Paris – Compartiment A (Mid-caps)
  • Main Index :
  • CAC AllShares
  • Other Indices :
  • CAC Mid,CAC Mid Small 190,CAC Small90,SBF SM,SBF250
  • Trading Place :
  • Euronext Paris (France)